| Schedule of Disaggregation of Revenue |
The following table presents the Company’s net sales disaggregated by major products within each segment as follows for the years ended December 31: | | | | | | | | | | | | | | | | | | | | | | | | | | | 2025 | | 2024 | | 2023 | | U.S. | | | | | | | | | | Pain Treatments | | | | | $ | 248,237 | | | $ | 234,936 | | | $ | 197,954 | | | Surgical Solutions | | | | | 180,442 | | | 167,706 | | | 141,888 | | | Restorative Therapies | | | | | 73,418 | | | 104,167 | | | 110,018 | | | Total U.S. net sales | | | | | 502,097 | | | 506,809 | | | 449,860 | | | | | | | | | | | | | International | | | | | | | | | | Pain Treatments | | | | | 30,823 | | | 26,353 | | | 22,847 | | | Surgical Solutions | | | | | 23,211 | | | 21,549 | | | 19,715 | | | Restorative Therapies | | | | | 11,956 | | | 18,569 | | | 19,923 | | | Total International net sales | | | | | 65,990 | | | 66,471 | | | 62,485 | | | | | | | | | | | | | Total net sales | | | | | $ | 568,087 | | | $ | 573,280 | | | $ | 512,345 | |
|